DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Exhibition & Sponsorship Opportunities
    • Attending Exhibitors and Sponsors
    • The DDL Incubator
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • RDD 2027
  • The Aerosol Society logo
Gonçalo Farias

Gonçalo Farias

Aptar Pharma

Paper:

Download Paper

Gonçalo Farias is currently working as a Laboratory Manager for Nasal and Innovation Services at Aptar Pharma (France). He holds an MSc in Pharmaceutical Sciences from the University of Lisbon, Portugal (2014), and a Ph.D. in Pharmacy & Pharmacology from the University of Bath, UK (2021). During his PhD, he focused on the investigation of formulation design and structure of orally inhaled and nasal pharmaceutical formulation systems, where he worked on a couple of FDA funded programmes focused on the application of techniques such as morphologically-directed Raman spectroscopy and dissolution to these products. His work has been published in peer-reviewed journals. Gonçalo Farias worked at Nanopharm Ltd, an Aptar Pharma Company (UK), as Head of Pharmaceutical Development and joined Aptar Pharma (France) in 2021 to support the analytical development, innovation and nasal device development studies. He is also a member of the Biopharmaceutics Technical Committee (PQRI).

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk